535 related articles for article (PubMed ID: 5374484)
1. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
[No Abstract] [Full Text] [Related]
2. Introduction. Symposium on copper metabolism and Wilson's disease.
Goldstein NP; Owen CA
Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
[No Abstract] [Full Text] [Related]
3. Effects of penicillamine therapy and low-copper diet on dysarthria in Wilson's disease (hepatolenticular degeneration).
Berry WR; Aronson AE; Darley FL; Goldstein NP
Mayo Clin Proc; 1974 Jun; 49(6):405-8. PubMed ID: 4835812
[No Abstract] [Full Text] [Related]
4. Treatment of hepatolenticular degeneration. (Wilson's disease).
Spellberg MA
Am J Gastroenterol; 1969 Aug; 52(2):121-6. PubMed ID: 4979739
[No Abstract] [Full Text] [Related]
5. [On hepatolenticular degeneration (Wilson's disease). 3. Hepatic localization of Cu64: scintigraphic and dynamic study before and after treatment with BAL and D-penicillamine].
D'Addabbo A; Damato VD; Germinario L; Campanella G; Boccuni N
Acta Neurol (Napoli); 1971; 26(4):436-48. PubMed ID: 5132825
[No Abstract] [Full Text] [Related]
6. [New views on the etiology, diagnosis and therapy of Wilson's disease].
Linke A
Z Arztl Fortbild (Jena); 1967 Dec; 61(24):1273-6. PubMed ID: 4873428
[No Abstract] [Full Text] [Related]
7. Treatment of Wilson's disease.
Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
[No Abstract] [Full Text] [Related]
8. [Liver copper determination in long-term treatment of Wilson's disease with D-penicillamine].
Lange J; Brandt G
Med Welt; 1981 Jan; 32(3):109-10. PubMed ID: 7207132
[No Abstract] [Full Text] [Related]
9. [Checking of urinary copper in patients with Wilson's disease during treatment with D-penicillamine].
Indaco A; Pellegrino L; Campanella G
Acta Neurol Quad (Napoli); 1979; 39():160-4. PubMed ID: 555232
[No Abstract] [Full Text] [Related]
10. Wilson's disease (hepatolenticular degeneration). Treatment with penicillamine and changes in hepatic trapping of radioactive copper.
Goldstein NP; Tauxe WN; McCall JT; Randall RV; Gross JB
Arch Neurol; 1971 May; 24(5):391-400. PubMed ID: 5554863
[No Abstract] [Full Text] [Related]
11. Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease.
Falkmer S; Samuelson G; Sjölin S
Pediatrics; 1970 Feb; 45(2):260-8. PubMed ID: 5413388
[No Abstract] [Full Text] [Related]
12. [Penicillamine treatment of Wilson's disease].
Falkmer S; Samuelson G; Sjölin S
Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
[No Abstract] [Full Text] [Related]
13. [Wilson's disease (hepatolenticular degeneration)].
Bickel H
Internist (Berl); 1966 Jan; 7(1):27-33 passim. PubMed ID: 4964272
[No Abstract] [Full Text] [Related]
14. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
[No Abstract] [Full Text] [Related]
15. Wilson's disease: the role of penicillamine.
Carmichael BM
Mil Med; 1969 Oct; 134(11):1336-9. PubMed ID: 4980975
[No Abstract] [Full Text] [Related]
16. Some therapeutic observations in Wilson's disease.
Shoulson I; Goldblatt D; Plassche W; Wilson G
Adv Neurol; 1983; 37():239-46. PubMed ID: 6858775
[No Abstract] [Full Text] [Related]
17. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
18. What Wilson's disease and its treatment have taught us about the metabolism of copper. Observations in 27 cases.
Goldstein NP; Tauxe WN; McCall JT; Randall RV; Gross JB
Med Clin North Am; 1968 Jul; 52(4):989-1001. PubMed ID: 5742073
[No Abstract] [Full Text] [Related]
19. Ophthalmoscopic changes in a patient with Wilson's disease during long-term penicillamine therapy.
Dingle J; Havener WH
Ann Ophthalmol; 1978 Sep; 10(9):1227-30. PubMed ID: 736410
[TBL] [Abstract][Full Text] [Related]
20. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]